Obesity
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
Single-strand conformation polymorphism and heteroduplex analysis of the coding region of the UCP1 gene was performed in 56 subjects randomly selected at the draft board examination from a cohort of 156 males with juvenile-onset obesity.
|
9398715 |
1997 |
Obesity
|
0.400 |
Biomarker
|
disease |
BEFREE |
We now report the discovery of a gene that codes for a novel uncoupling protein, designated UCP2, which has 59% amino-acid identity to UCP1, and describe properties consistent with a role in diabetes and obesity.
|
9054939 |
1997 |
Obesity
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
To study associations of UCP gene expression with human obesity, we determined, by a competitive reverse transcription-polymerase chain reaction assay, UCP mRNA expression levels in intra- and extraperitoneal adipose tissues of 79 obese subjects and 17 lean controls.
|
9374134 |
1997 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
We now report the discovery of a gene that codes for a novel uncoupling protein, designated UCP2, which has 59% amino-acid identity to UCP1, and describe properties consistent with a role in diabetes and obesity.
|
9054939 |
1997 |
Diabetes Mellitus
|
0.100 |
Biomarker
|
group |
BEFREE |
We now report the discovery of a gene that codes for a novel uncoupling protein, designated UCP2, which has 59% amino-acid identity to UCP1, and describe properties consistent with a role in diabetes and obesity.
|
9054939 |
1997 |
Lymphoma
|
0.020 |
Biomarker
|
group |
BEFREE |
The immunophenotypic profiles of UCP-L were confirmed to correspond to the presumptive lymphoma cell population by use of a live gating procedure on the large cells, which eliminated interference by reactive cells or necrotic tissue fragments.
|
9369423 |
1997 |
Adult Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The immunophenotypic profiles of UCP-L were confirmed to correspond to the presumptive lymphoma cell population by use of a live gating procedure on the large cells, which eliminated interference by reactive cells or necrotic tissue fragments.
|
9369423 |
1997 |
Childhood Lymphoma
|
0.020 |
Biomarker
|
disease |
BEFREE |
The immunophenotypic profiles of UCP-L were confirmed to correspond to the presumptive lymphoma cell population by use of a live gating procedure on the large cells, which eliminated interference by reactive cells or necrotic tissue fragments.
|
9369423 |
1997 |
Hodgkin Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Using this method, we identified UCP-L in 208 of 293 (71%) consecutive cases of non-Hodgkin's lymphomas, while no UCP-L were seen in 72 cases of non-specific hyperplasia of lymph nodes.
|
9369423 |
1997 |
Lymphoma, Non-Hodgkin
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
When those cases were eliminated from the analysis, 80% of non-Hodgkin's lymphoma were found to contain UCP-L.
|
9369423 |
1997 |
T-Cell Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
The common morphology of UCP-L as defined by forward and side scatter grams was consistent with a 'lymphoid appearance' except in several cases of HTLV-I-positive T cell lymphoma and gammadelta T cell lymphoma.
|
9369423 |
1997 |
Adult Hodgkin Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Only one of 21 cases of Hodgkin's lymphoma was found to have UCP-L.
|
9369423 |
1997 |
Adult Non-Hodgkin Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
When those cases were eliminated from the analysis, 80% of non-Hodgkin's lymphoma were found to contain UCP-L.
|
9369423 |
1997 |
Childhood Non-Hodgkin Lymphoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
When those cases were eliminated from the analysis, 80% of non-Hodgkin's lymphoma were found to contain UCP-L.
|
9369423 |
1997 |
Childhood Hodgkin Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Only one of 21 cases of Hodgkin's lymphoma was found to have UCP-L.
|
9369423 |
1997 |
extranodal lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
In B cell lymphoma, the incidence of UCP-L in nodal lymphomas (80%) was much higher than in extranodal lymphomas (47%).
|
9369423 |
1997 |
Lymphoma, Non-Hodgkin, Familial
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
When those cases were eliminated from the analysis, 80% of non-Hodgkin's lymphoma were found to contain UCP-L.
|
9369423 |
1997 |
Obesity
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Human UCP3 is different from UCP1 and UCP2 by its high and preferential expression in skeletal muscle and consequently the UCP3 gene is an attractive candidate gene for obesity.
|
9498661 |
1998 |
Obesity
|
0.400 |
AlteredExpression
|
disease |
BEFREE |
Uncoupling protein-1 mRNA expression in obese human subjects: the role of sequence variations at the uncoupling protein-1 gene locus.
|
9555947 |
1998 |
Hyperlipidemia, Familial Combined
|
0.010 |
Biomarker
|
disease |
BEFREE |
The frequency of the polymorphisms of the beta3-AR and UCP1 genes did not differ between patients with FCHL and controls.
|
9826220 |
1998 |
Obesity
|
0.400 |
GeneticVariation
|
disease |
BEFREE |
It was the aim of this study to examine the allelic frequency and the prevalence of the three UCP-1 genotypes in a broad caucasian cohort and to investigate the significance of this polymorphism for obesity and diabetes.
|
10469165 |
1999 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
It was the aim of this study to examine the allelic frequency and the prevalence of the three UCP-1 genotypes in a broad caucasian cohort and to investigate the significance of this polymorphism for obesity and diabetes.
|
10469165 |
1999 |
Diabetes Mellitus
|
0.100 |
GeneticVariation
|
group |
BEFREE |
It was the aim of this study to examine the allelic frequency and the prevalence of the three UCP-1 genotypes in a broad caucasian cohort and to investigate the significance of this polymorphism for obesity and diabetes.
|
10469165 |
1999 |
Metabolic Diseases
|
0.100 |
Biomarker
|
group |
BEFREE |
Very recently, the cloning of UCP2 and UCP3, two homologues of UCP1, has renewed the field of research on the importance of respiration control in metabolic processes and metabolic diseases.
|
10395193 |
1999 |
Metabolic Diseases
|
0.100 |
GeneticVariation
|
group |
BEFREE |
The recently described A-->G (-3826) point mutation within the distal region of the UCP-1 promoter is possibly involved in the development of obesity, diabetes and related metabolic disorders.
|
10469165 |
1999 |